logo

For the Inventor, By the Inventor

Wilmington, DE, United States of America

Robert E Waltermire

This inventor holds 4 USPTO granted patents. Top assignees: Dupont Pharmaceuticals Company, Bristol-Myers Squibb Pharma Company, The Dupont Merck Pharmaceutical Company. Active years: 1996-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert E Waltermire. Retrieved from https://idiyas.com/inventor/robert-e-waltermire

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 24(Granted Patents)


Location History:

  • Wimington, DE (US) (1996)
  • Wilmington, DE (US) (1999 - 2002)

Company Filing History:

goldMedal2 out of 106 
 
Dupont Pharmaceuticals Company
 patents
silverMedal1 out of 234 
 
Bristol-Myers Squibb Pharma Company
 patents
bronzeMedal1 out of 206 
 
The Dupont Merck Pharmaceutical Company
 patents

Years Active: 1996-2002

Loading Chart...
4 patents (USPTO):Explore Patents
1. 6452000 - Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate (2002-09-17),
2. 6218534 - Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate (2001-04-17),
3. 5932749 - Asymmetric synthesis of R-.alpha.-propyl-piperonyl amine and its analogs (1999-08-03),
4. 5530124 - Method for preparing cyclic ureas and their use for the synthesis of HIV (1996-06-25),

Title: The Innovations of Robert E. Waltermire

Introduction

Robert E. Waltermire is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of chemistry, particularly in the preparation of asymmetric cyclic ureas. With a total of 4 patents to his name, Waltermire's work has had a lasting impact on pharmaceutical research and development.

Latest Patents

One of his latest patents is focused on the "Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate." This innovative approach has the potential to enhance the efficiency of synthesizing complex chemical compounds. His work in this area demonstrates his commitment to advancing chemical methodologies.

Career Highlights

Throughout his career, Waltermire has worked with prominent companies such as DuPont Pharmaceuticals Company and Bristol-Myers Squibb Pharma Company. His experience in these leading organizations has allowed him to contribute to groundbreaking research and development projects.

Collaborations

Waltermire has collaborated with esteemed colleagues, including Luigi Anzalone and Gregory D. Harris. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Robert E. Waltermire's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence the pharmaceutical industry and inspire future research endeavors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…